Viewing Study NCT01722968


Ignite Creation Date: 2025-12-24 @ 5:44 PM
Ignite Modification Date: 2025-12-28 @ 9:14 PM
Study NCT ID: NCT01722968
Status: COMPLETED
Last Update Posted: 2019-02-27
First Post: 2012-10-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Biomarker Study in Patients With HER2-negative Metastatic Breast Cancer Treated With Bevacizumab and Paclitaxel
Sponsor: Theodoros Foukakis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module